Related Experiment Videos

Protection against stroke and dementia: an update on the latest clinical trial evidence

Bryan Williams1

  • 1Department of Cardiovascular Sciences, University of Leicester, Clinical Sciences Building, PO Box 65, Leicester Royal Infirmary, Leicester, LE2 7LX, UK. bw17@le.ac.uk

Current Hypertension Reports
|July 20, 2004
PubMed

Insights

Lowering blood pressure (BP) significantly reduces stroke risk. For high-risk patients, drug therapy, including aspirin, is vital for preventing cardiovascular and cerebrovascular complications.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Pharmacology

Background:

  • Meta-analyses investigate the link between blood pressure reduction and risks of stroke and dementia.
  • Drug therapy reducing systolic BP by 10 mm Hg offers significant stroke protection.

Purpose of the Study:

  • To review current evidence on blood pressure-lowering strategies for stroke and dementia prevention.
  • To examine the efficacy of different drug classes and delivery strategies for BP management.

Main Methods:

  • Review of recent meta-analyses and studies on antihypertensive therapies.
  • Analysis of comparative effectiveness of various drug regimens (diuretics, beta-blockers, ACE inhibitors, CCBs, ARBs, statins).

Main Results:

  • Established benefit of BP reduction for stroke prevention.
  • Ongoing debate regarding optimal drug regimens and primary vs. secondary prevention strategies.
  • Consensus on the necessity of drug therapy, including aspirin, for high-risk individuals.

Conclusions:

  • Effective blood pressure management is crucial for reducing stroke and dementia risk.
  • The choice of antihypertensive medication and strategy may vary, but intervention is key for high-risk patients.
  • Aggressive pharmacologic intervention, including aspirin, is vital for preventing major cardiovascular and cerebrovascular events in at-risk populations.

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...